Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
M Li, W Zhang, B Wang, Y Gao, Z Song… - International Journal of …, 2016 - Taylor & Francis
Hepatocellular carcinoma (HCC) is the most common primary liver cancer with high
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …
morbidity and mortality worldwide. Chemotherapy is recommended to patients with …
Oncogenic signaling in tumorigenesis and applications of siRNA nanotherapeutics in breast cancer
Overexpression of oncogenes and cross-talks of the oncoproteins-regulated signaling
cascades with other intracellular pathways in breast cancer could lead to massive abnormal …
cascades with other intracellular pathways in breast cancer could lead to massive abnormal …
Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology
AG Mares, G Pacassoni, JS Marti, S Pujals… - PLoS …, 2021 - journals.plos.org
Amphiphilic block co-polymer nanoparticles are interesting candidates for drug delivery as a
result of their unique properties such as the size, modularity, biocompatibility and drug …
result of their unique properties such as the size, modularity, biocompatibility and drug …
Preliminary assays towards melanoma cells using phototherapy with gold-based nanomaterials
Cancer like melanoma is a complex disease, for which standard therapies have significant
adverse side effects that in most cases are ineffective and highly unspecific. Thus, a new …
adverse side effects that in most cases are ineffective and highly unspecific. Thus, a new …
Silica‐based organic‐inorganic hybrid nanoparticles and nanoconjugates for improved anticancer drug delivery
After the introduction of first generation MSNs for drug delivery with some challenges such
as large particle sizes, irregular morphologies and aggregations, second generation …
as large particle sizes, irregular morphologies and aggregations, second generation …